カテゴリー： 世界, 医療/バイオ, LP Information

世界のmRNA新型コロナウイルスワクチン市場予測 2023年-2029年

【英語タイトル】Global mRNA COVID-19 Vaccine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00937）・商品コード：LP23DC00937
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：99
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のmRNA新型コロナウイルスワクチン市場」は、過去の販売実績から2022年の世界のmRNA新型コロナウイルスワクチンの総販売量を検討し、2023年から2029年の予測されるmRNA新型コロナウイルスワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のmRNA新型コロナウイルスワクチンの市場規模を掲載し、XXX百万米ドル規模の世界のmRNA新型コロナウイルスワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界のmRNA新型コロナウイルスワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のmRNA新型コロナウイルスワクチン市場における各社の独自のポジションをより深く理解するために、mRNA新型コロナウイルスワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のmRNA新型コロナウイルスワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。mRNA新型コロナウイルスワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。mRNA新型コロナウイルスワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。mRNA新型コロナウイルスワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

mRNA新型コロナウイルスワクチンの世界主要メーカーとしては、Moderna、 CanSino Biologicals、 Pfizer、 Fosun-Pharmaceutical、 CSPC Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のmRNA新型コロナウイルスワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではmRNA新型コロナウイルスワクチン市場をセグメンテーションし、種類別 (非複製型mRNAワクチン、自己増幅型mRNAワクチン)、用途別 (子供、大人)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：非複製型mRNAワクチン、自己増幅型mRNAワクチン

・用途別区分：子供、大人

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のmRNA新型コロナウイルスワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見たmRNA新型コロナウイルスワクチン市場成長の要因は何か？
・mRNA新型コロナウイルスワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・mRNA新型コロナウイルスワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：mRNA新型コロナウイルスワクチンの年間販売量2018-2029、地域別現状・将来分析
・mRNA新型コロナウイルスワクチンの種類別セグメント：非複製型mRNAワクチン、自己増幅型mRNAワクチン
・mRNA新型コロナウイルスワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・mRNA新型コロナウイルスワクチンの用途別セグメント：子供、大人
・mRNA新型コロナウイルスワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のmRNA新型コロナウイルスワクチン市場
・企業別のグローバルmRNA新型コロナウイルスワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のmRNA新型コロナウイルスワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別のmRNA新型コロナウイルスワクチン販売価格
・主要企業のmRNA新型コロナウイルスワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

mRNA新型コロナウイルスワクチンの地域別レビュー
・地域別のmRNA新型コロナウイルスワクチン市場規模2018-2023：年間販売量、売上
・主要国別のmRNA新型コロナウイルスワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカのmRNA新型コロナウイルスワクチン販売の成長
・アジア太平洋のmRNA新型コロナウイルスワクチン販売の成長
・ヨーロッパのmRNA新型コロナウイルスワクチン販売の成長
・中東・アフリカのmRNA新型コロナウイルスワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別のmRNA新型コロナウイルスワクチン販売量、売上（2018-2023）
・南北アメリカのmRNA新型コロナウイルスワクチンの種類別販売量
・南北アメリカのmRNA新型コロナウイルスワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のmRNA新型コロナウイルスワクチン販売量、売上（2018-2023）
・アジア太平洋のmRNA新型コロナウイルスワクチンの種類別販売量
・アジア太平洋のmRNA新型コロナウイルスワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のmRNA新型コロナウイルスワクチン販売量、売上（2018-2023）
・ヨーロッパのmRNA新型コロナウイルスワクチンの種類別販売量
・ヨーロッパのmRNA新型コロナウイルスワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のmRNA新型コロナウイルスワクチン販売量、売上（2018-2023）
・中東・アフリカのmRNA新型コロナウイルスワクチンの種類別販売量
・中東・アフリカのmRNA新型コロナウイルスワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・mRNA新型コロナウイルスワクチンの製造コスト構造分析
・mRNA新型コロナウイルスワクチンの製造プロセス分析
・mRNA新型コロナウイルスワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・mRNA新型コロナウイルスワクチンの主要なグローバル販売業者
・mRNA新型コロナウイルスワクチンの主要なグローバル顧客

地域別のmRNA新型コロナウイルスワクチン市場予測レビュー
・地域別のmRNA新型コロナウイルスワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・mRNA新型コロナウイルスワクチンの種類別市場規模予測
・mRNA新型コロナウイルスワクチンの用途別市場規模予測

主要企業分析
Moderna、 CanSino Biologicals、 Pfizer、 Fosun-Pharmaceutical、 CSPC Pharmaceutical
・企業情報
・mRNA新型コロナウイルスワクチン製品
・mRNA新型コロナウイルスワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global mRNA COVID-19 Vaccine market size is projected to grow from US$ 4138 million in 2022 to US$ 4544.8 million in 2029; it is expected to grow at a CAGR of 1.3% from 2023 to 2029.
United States market for mRNA COVID-19 Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for mRNA COVID-19 Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for mRNA COVID-19 Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key mRNA COVID-19 Vaccine players cover Moderna, CanSino Biologicals, Pfizer, Fosun-Pharmaceutical and CSPC Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “mRNA COVID-19 Vaccine Industry Forecast” looks at past sales and reviews total world mRNA COVID-19 Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected mRNA COVID-19 Vaccine sales for 2023 through 2029. With mRNA COVID-19 Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA COVID-19 Vaccine industry.
This Insight Report provides a comprehensive analysis of the global mRNA COVID-19 Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA COVID-19 Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA COVID-19 Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA COVID-19 Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA COVID-19 Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA COVID-19 Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Segmentation by application
Children
Adults
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global mRNA COVID-19 Vaccine market?
What factors are driving mRNA COVID-19 Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA COVID-19 Vaccine market opportunities vary by end market size?
How does mRNA COVID-19 Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA COVID-19 Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for mRNA COVID-19 Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for mRNA COVID-19 Vaccine by Country/Region, 2018, 2022 & 2029
2.2 mRNA COVID-19 Vaccine Segment by Type
2.2.1 Non-replicating mRNA Vaccine
2.2.2 Self-amplifying mRNA Vaccine
2.3 mRNA COVID-19 Vaccine Sales by Type
2.3.1 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global mRNA COVID-19 Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global mRNA COVID-19 Vaccine Sale Price by Type (2018-2023)
2.4 mRNA COVID-19 Vaccine Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 mRNA COVID-19 Vaccine Sales by Application
2.5.1 Global mRNA COVID-19 Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global mRNA COVID-19 Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global mRNA COVID-19 Vaccine Sale Price by Application (2018-2023)
3 Global mRNA COVID-19 Vaccine by Company
3.1 Global mRNA COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global mRNA COVID-19 Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global mRNA COVID-19 Vaccine Sales Market Share by Company (2018-2023)
3.2 Global mRNA COVID-19 Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global mRNA COVID-19 Vaccine Revenue by Company (2018-2023)
3.2.2 Global mRNA COVID-19 Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global mRNA COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers mRNA COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA COVID-19 Vaccine Product Location Distribution
3.4.2 Players mRNA COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for mRNA COVID-19 Vaccine by Geographic Region
4.1 World Historic mRNA COVID-19 Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global mRNA COVID-19 Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global mRNA COVID-19 Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic mRNA COVID-19 Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global mRNA COVID-19 Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global mRNA COVID-19 Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas mRNA COVID-19 Vaccine Sales Growth
4.4 APAC mRNA COVID-19 Vaccine Sales Growth
4.5 Europe mRNA COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa mRNA COVID-19 Vaccine Sales Growth
5 Americas
5.1 Americas mRNA COVID-19 Vaccine Sales by Country
5.1.1 Americas mRNA COVID-19 Vaccine Sales by Country (2018-2023)
5.1.2 Americas mRNA COVID-19 Vaccine Revenue by Country (2018-2023)
5.2 Americas mRNA COVID-19 Vaccine Sales by Type
5.3 Americas mRNA COVID-19 Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA COVID-19 Vaccine Sales by Region
6.1.1 APAC mRNA COVID-19 Vaccine Sales by Region (2018-2023)
6.1.2 APAC mRNA COVID-19 Vaccine Revenue by Region (2018-2023)
6.2 APAC mRNA COVID-19 Vaccine Sales by Type
6.3 APAC mRNA COVID-19 Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe mRNA COVID-19 Vaccine by Country
7.1.1 Europe mRNA COVID-19 Vaccine Sales by Country (2018-2023)
7.1.2 Europe mRNA COVID-19 Vaccine Revenue by Country (2018-2023)
7.2 Europe mRNA COVID-19 Vaccine Sales by Type
7.3 Europe mRNA COVID-19 Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA COVID-19 Vaccine by Country
8.1.1 Middle East & Africa mRNA COVID-19 Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa mRNA COVID-19 Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa mRNA COVID-19 Vaccine Sales by Type
8.3 Middle East & Africa mRNA COVID-19 Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA COVID-19 Vaccine
10.3 Manufacturing Process Analysis of mRNA COVID-19 Vaccine
10.4 Industry Chain Structure of mRNA COVID-19 Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA COVID-19 Vaccine Distributors
11.3 mRNA COVID-19 Vaccine Customer
12 World Forecast Review for mRNA COVID-19 Vaccine by Geographic Region
12.1 Global mRNA COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global mRNA COVID-19 Vaccine Forecast by Region (2024-2029)
12.1.2 Global mRNA COVID-19 Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global mRNA COVID-19 Vaccine Forecast by Type
12.7 Global mRNA COVID-19 Vaccine Forecast by Application
13 Key Players Analysis
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.1.3 Moderna mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 CanSino Biologicals
13.2.1 CanSino Biologicals Company Information
13.2.2 CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CanSino Biologicals Main Business Overview
13.2.5 CanSino Biologicals Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.3.3 Pfizer mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Fosun-Pharmaceutical
13.4.1 Fosun-Pharmaceutical Company Information
13.4.2 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fosun-Pharmaceutical Main Business Overview
13.4.5 Fosun-Pharmaceutical Latest Developments
13.5 CSPC Pharmaceutical
13.5.1 CSPC Pharmaceutical Company Information
13.5.2 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CSPC Pharmaceutical Main Business Overview
13.5.5 CSPC Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. mRNA COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. mRNA COVID-19 Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Non-replicating mRNA Vaccine
Table 4. Major Players of Self-amplifying mRNA Vaccine
Table 5. Global mRNA COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global mRNA COVID-19 Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global mRNA COVID-19 Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global mRNA COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global mRNA COVID-19 Vaccine Revenue by Application (2018-2023)
Table 13. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global mRNA COVID-19 Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global mRNA COVID-19 Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global mRNA COVID-19 Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global mRNA COVID-19 Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global mRNA COVID-19 Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global mRNA COVID-19 Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers mRNA COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players mRNA COVID-19 Vaccine Products Offered
Table 22. mRNA COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global mRNA COVID-19 Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global mRNA COVID-19 Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global mRNA COVID-19 Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global mRNA COVID-19 Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global mRNA COVID-19 Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global mRNA COVID-19 Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global mRNA COVID-19 Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global mRNA COVID-19 Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas mRNA COVID-19 Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas mRNA COVID-19 Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas mRNA COVID-19 Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas mRNA COVID-19 Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas mRNA COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas mRNA COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC mRNA COVID-19 Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC mRNA COVID-19 Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC mRNA COVID-19 Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC mRNA COVID-19 Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC mRNA COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC mRNA COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe mRNA COVID-19 Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe mRNA COVID-19 Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe mRNA COVID-19 Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe mRNA COVID-19 Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe mRNA COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe mRNA COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa mRNA COVID-19 Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa mRNA COVID-19 Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa mRNA COVID-19 Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa mRNA COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa mRNA COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of mRNA COVID-19 Vaccine
Table 58. Key Market Challenges & Risks of mRNA COVID-19 Vaccine
Table 59. Key Industry Trends of mRNA COVID-19 Vaccine
Table 60. mRNA COVID-19 Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. mRNA COVID-19 Vaccine Distributors List
Table 63. mRNA COVID-19 Vaccine Customer List
Table 64. Global mRNA COVID-19 Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global mRNA COVID-19 Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas mRNA COVID-19 Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas mRNA COVID-19 Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC mRNA COVID-19 Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC mRNA COVID-19 Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe mRNA COVID-19 Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe mRNA COVID-19 Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa mRNA COVID-19 Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa mRNA COVID-19 Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global mRNA COVID-19 Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global mRNA COVID-19 Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global mRNA COVID-19 Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global mRNA COVID-19 Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Moderna Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Moderna mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 80. Moderna mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Moderna Main Business
Table 82. Moderna Latest Developments
Table 83. CanSino Biologicals Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 85. CanSino Biologicals mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CanSino Biologicals Main Business
Table 87. CanSino Biologicals Latest Developments
Table 88. Pfizer Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 90. Pfizer mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Fosun-Pharmaceutical Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 95. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Fosun-Pharmaceutical Main Business
Table 97. Fosun-Pharmaceutical Latest Developments
Table 98. CSPC Pharmaceutical Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 100. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. CSPC Pharmaceutical Main Business
Table 102. CSPC Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of mRNA COVID-19 Vaccine
Figure 2. mRNA COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA COVID-19 Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global mRNA COVID-19 Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. mRNA COVID-19 Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Non-replicating mRNA Vaccine
Figure 10. Product Picture of Self-amplifying mRNA Vaccine
Figure 11. Global mRNA COVID-19 Vaccine Sales Market Share by Type in 2022
Figure 12. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. mRNA COVID-19 Vaccine Consumed in Children
Figure 14. Global mRNA COVID-19 Vaccine Market: Children (2018-2023) & (K Units)
Figure 15. mRNA COVID-19 Vaccine Consumed in Adults
Figure 16. Global mRNA COVID-19 Vaccine Market: Adults (2018-2023) & (K Units)
Figure 17. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2022)
Figure 18. Global mRNA COVID-19 Vaccine Revenue Market Share by Application in 2022
Figure 19. mRNA COVID-19 Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global mRNA COVID-19 Vaccine Sales Market Share by Company in 2022
Figure 21. mRNA COVID-19 Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global mRNA COVID-19 Vaccine Revenue Market Share by Company in 2022
Figure 23. Global mRNA COVID-19 Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global mRNA COVID-19 Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas mRNA COVID-19 Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas mRNA COVID-19 Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC mRNA COVID-19 Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC mRNA COVID-19 Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe mRNA COVID-19 Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe mRNA COVID-19 Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa mRNA COVID-19 Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa mRNA COVID-19 Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas mRNA COVID-19 Vaccine Sales Market Share by Country in 2022
Figure 34. Americas mRNA COVID-19 Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas mRNA COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas mRNA COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC mRNA COVID-19 Vaccine Sales Market Share by Region in 2022
Figure 42. APAC mRNA COVID-19 Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC mRNA COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC mRNA COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe mRNA COVID-19 Vaccine Sales Market Share by Country in 2022
Figure 53. Europe mRNA COVID-19 Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe mRNA COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe mRNA COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa mRNA COVID-19 Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country mRNA COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of mRNA COVID-19 Vaccine in 2022
Figure 71. Manufacturing Process Analysis of mRNA COVID-19 Vaccine
Figure 72. Industry Chain Structure of mRNA COVID-19 Vaccine
Figure 73. Channels of Distribution
Figure 74. Global mRNA COVID-19 Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global mRNA COVID-19 Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global mRNA COVID-19 Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のmRNA新型コロナウイルスワクチン市場予測 2023年-2029年] (コード：LP23DC00937)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のmRNA新型コロナウイルスワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の経口新型コロナウイルス感染症ワクチン市場予測 2023年-2029年
  • 世界のmRNAワクチンコア酵素市場予測 2023年-2029年
  • 世界の吸入用組換え新型コロナウイルスワクチン市場予測 2023年-2029年
  • mRNAワクチン＆治療薬の世界市場 2022年-2026年
  • 世界の滅菌自己無効化ワクチン注射器市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆